| Sanofi-Aventis access policy 'shows real achievements' | Posted on 13/03/2007 in Pharmaceutical Company Restructures Sanofi-Aventis has announced that its plans to improve access to medicine to southern hemisphere countries have exhibited genuine achievements.
The company's access to medicines division aims to provide healthcare services to the 80 per cent of the world with limited or absent access to basic medication, with a focus on southern hemisphere countries that are lacking social healthcare systems.
Sanofi-Aventis reports that it has seen major successes in vaccines in addition to five distinct therapeutic fields - epilepsy, leishmaniasis, malaria, sleeping sickness and tuberculosis.
Programmes include training schemes for general practitioners in remote parts of Mali, non-profit pricing systems for some drugs and continued research, development and eduction.
Jean-Francois Dehecq, president of Sanofi-Aventis, said: "All of these initiatives are being undertaken voluntarily and in keeping with the historic heritage of the Sanofi-Aventis group.
"This is our duty as a major international player in the field of pharmaceuticals and vaccines."
He added that the company was supporting these programmes with its abilities in innovation and its desire to continue to exploit its older products, while the company is also aiming to meet the vital challenges for the industry in the southern hemisphere.
Earlier this month, Sanofi-Aventis announced the availability in sub-Saharan Africa of a fixed-dose combination of artesunate and amodiaquine for the treatment of malaria.Other news stories from 13/03/2007
Read more in the Zenopa News Archive
How this news is generated
|  |
|
